Cancerous tumours of the pancreas

Last medical review:

A cancerous tumour of the pancreas can grow into nearby tissue and destroy it. The tumour can also spread (metastasize) to other parts of the body. Cancerous tumours are also called malignant tumours.

Pancreatic ductal adenocarcinoma (PDAC)

Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer. It makes up about 85% to 95% of all pancreatic cancer cases. PDAC starts in ductal cells, which are the exocrine cells that line the inner walls of the pancreatic ducts. Most cases of PDAC start in the head of the pancreas, but they can also occur in the body or tail.

There are 2 main subtypes of PDAC that are categorized by the patterns of gene expression and different types of mutations in the cancer cells:

  • classical
  • squamous- or basal-like

The classical subtype of PDAC typically has a better prognosis than the basal-like subtype.

PDAC is an aggressive cancer. It typically grows quickly and has usually spread to other parts of the body (metastasized) by the time it is diagnosed.

Neuroendocrine tumours

Neuroendocrine tumours of the pancreas (pancreatic NETs, or pNETs) start in the endocrine cells of the pancreas. They make up about 2% to 7% of all pancreatic cancers. They are sometimes called islet cell tumours.

Find out more about neuroendocrine tumours of the pancreas.

Rare pancreatic tumours

Rare cancerous tumours of the pancreas include:

  • acinar cell carcinoma
  • squamous cell carcinoma
  • adenosquamous carcinoma
  • colloid non-cystic adenocarcinoma
  • small cell carcinoma
  • sarcoma
  • lymphoma
  • pancreatoblastoma
  • giant cell carcinoma (also called pleomorphic adenocarcinoma)
  • hepatoid carcinoma
  • signet ring carcinoma
  • medullary carcinoma

Each of these types of tumours makes up a very small number of all cases of pancreatic cancer.

Expert review and references

  • American Cancer Society. Key Statistics for Pancreatic Neuroendocrine Tumor. 2023. https://www.cancer.org/.
  • American Cancer Society. What is Pancreatic Cancer. 2024. https://www.cancer.org/.
  • Fisher GA. Gastroenteropancreatic Neuroendocrine Tumours. Yalcin S, Phillip PA (eds.). Textbook of Gastrointestinal Oncology. Springer Nature Switzerland; 2019: 16:264–282.
  • Froeling FEM, Casolino R, Pea A, Biankin AV, Chang DK. Molecular subtyping and precision medicine for pancreatic cancer. Journal of Clinical Medicine. 2021: 10(1):149.
  • Johns Hopkins Medicine. Pancreatic Cancer Types. Baltimore, MD: https://www.hopkinsmedicine.org/. May 29, 2024.
  • Fred Hutch Cancer Center. Pancreatic Ductal Adenocarcinoma Subtypes: What Your Type Means?. Seattle, WA: 2023. https://www.fredhutch.org/.
  • O'Kane GM, Grünwald BT, Jang GH, et al.. GATA6 expression distinguishes classical and basal-like subtypes in advanced pancreatic cancer. Clinical Cancer Research. 2020: 26(18):4901–4910.
  • Pancreatic Cancer Action Network. Types of Pancreatic Cancer. 2024. https://www.pancan.org/.
  • PDQ Adult Treatment Editorial Board. Pancreatic Cancer Treatment (PDQ®) – Patient Version. Bethesda, MD: National Cancer Institute; 2024. https://www.cancer.gov/.
  • Stevenson MA, Patel SH, Syed AA. Resectable and borderline resectable pancreatic cancer. Yalcin S, Phillip PA (eds.). Textbook of Gastrointestinal Oncology. Springer Nature Switzerland; 2019: 14:230–249.
  • Torres C, Grippo PJ. Pancreatic cancer subtypes: a roadmap for precision medicine. Annals of Medicine. 2018: 50(4):277–287.
  • Wang D, Rong Y, Wu W, Jin D. Primary small cell carcinoma of the pancreas: rare type of pancreatic cancer and review of the literatures. World Journal of Surgical Oncology. 2012: 10:32.
  • Winter JM, Brody JR, Abrams RA, Posey JA, Yeo CJ. Cancer of the pancreas. DeVita VT Jr, Lawrence TS, Rosenberg S. eds. DeVita Hellman and Rosenberg's Cancer: Principles and Practice of Oncology. 12th ed. Philadelphia, PA: Wolters Kluwer; 2023: Kindle version, chapter 55, https://read.amazon.ca/?asin=B0BG3DPT4Q&language=en-CA.
  • Xiong Q, Zhang Z, Xu Y, Zhu Q. Pancreatic adenosquamous carcinoma: A rare pathological subtype of pancreatic cancer. Journal of Clinical Medicine. 2022: 11(24):7401.

Your trusted source for accurate cancer information

With just $5 from readers like you, we can continue to provide the highest quality cancer information for over 100 types of cancer.

We’re here to ensure easy access to accurate cancer information for you and the millions of people who visit this website every year. But we can’t do it alone.

If everyone reading this gave just $5, we could achieve our goal this month to fund reliable cancer information, compassionate support services and the most promising research. Please give today because every contribution counts. Thank you.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on cancer.ca, nor do we endorse any service, product, treatment or therapy.


1-888-939-3333 | cancer.ca | © 2025 Canadian Cancer Society